# Cardiomyopathies and Heart Muscle Diseases: Cardiac Imaging in the Evaluation of Myocardial Fibrosis Transition

> **NCT06409585** · — · RECRUITING · sponsor: **University of Edinburgh** · enrollment: 290 (estimated)

## Conditions studied

- Heart Failure With Preserved Ejection Fraction
- Hypertrophic Cardiomyopathy
- Cardiac Sarcoidosis
- Hypertensive Heart Disease
- Tako Tsubo Cardiomyopathy
- Arrhythmogenic Right Ventricular Cardiomyopathy 1
- Myocarditis

## Interventions

- **DIAGNOSTIC_TEST:** 68Ga-FAPI or 18F-AlF-FAPI cardiac PET-MR
- **DIAGNOSTIC_TEST:** Echocardiogram
- **DIAGNOSTIC_TEST:** Cardiac MRI

## Key facts

- **NCT ID:** NCT06409585
- **Lead sponsor:** University of Edinburgh
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-01
- **Primary completion:** 2027-08-01
- **Final completion:** 2028-01-01
- **Target enrollment:** 290 (ESTIMATED)
- **Last updated:** 2025-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06409585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06409585, "Cardiomyopathies and Heart Muscle Diseases: Cardiac Imaging in the Evaluation of Myocardial Fibrosis Transition". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06409585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*